Matthew Hare

PhD Candidate


Bachelor of Medicine, Bachelor of Surgery Hons., 2012, Monash University; Honours Degree of Bachelor of Medical Science, 2012, Monash University 


Darwin Royal Darwin Hospital


After completing his undergraduate medical training, Matt undertook his residency and began specialist training in Endocrinology at The Alfred Hospital and later Monash Health in Melbourne.

He moved to Darwin in 2019 to start a PhD under the supervision of Prof Louise Maple-Brown looking at intergenerational trends in diabetes and cardiometabolic health. He also does clinical work in Endocrinology and General Medicine at Royal Darwin Hospital.

Matt has a longstanding interest in the epidemiology, determinants and prevention of non-communicable diseases, particularly those associated with diabetes and obesity.

He has previously completed an honours year working in diabetes epidemiology at Baker IDI Heart and Diabetes Institute in Melbourne and a brief placement with the MRC Epidemiology Unit at the University of Cambridge.

His PhD work is supported by a NHMRC Postgraduate Scholarship, the NHMRC/Diabetes Australia Postgraduate Award”  and the Douglas and Lola Douglas Scholarship in Medical Science from the Australian Academy of Science. 

1. Strelitz J, Ahern AL, Long G, Hare MJL, Irving G, Wareham NJ, Griffin SJ. Weight change following diabetes diagnosis and 10-year incidence of cardiovascular disease. Diabetologia, 2019; 62(8):1391-1402.

2. Hamblin PS, Wong R, Ekinci EI, Fourlanos S, Shah S, Jones AR, Hare MJL, Calder GL, Seneviratne Epa D, George EM, Giri R, Kotowicz MA, Kyi M, Lafontaine N, MacIsaac RJ, Nolan BJ, O’Neal DN, Renouf D, Varadarajan S, Wong J, Xu S, Bach LA. Sodium-Glucose Cotransporter 2 Inhibitors Increase the Risk of Diabetic Ketoacidosis in Type 2 Diabetes: A Retrospective Multi-center Controlled Cohort Study. Journal of Clinical Endocrinology and Metabolism, 2019; 104(8):3077-3087.

3. Hare MJL, Shaw JE (2019). “Cardiovascular Disease Risk in Diabetes Mellitus” in Sabanayagam C & Wong TY (Eds.), Frontiers in Diabetes: Diabetic Retinopathy and Cardiovascular Disease, v.27, p.1-19, Basel, Karger. DOI: 10.1159/000486261

4. Lee PC, Hare MJL, Bach LA. Making sense of treatment options for type 2 diabetes. Internal Medicine Journal, 2018; 48:762-769.

5. Qian SY, Hare MJL, Pham A, Topliss DJ. Insulinoma presenting with post-prandial hypoglycaemia following fundoplication. Endocrinology, Diabetes & Metabolism Case Reports, 2018: 17-0131

6. Polmear JM, Hare MJL, Catford SR, Topliss DJ, Dooley MJ. Use of anticoagulation in thyroid disease. Australian Family Physician, 2016; 45(3):109-111.

7. Hare MJL, Shaw JE. Ethnicity considerations in diagnosing glucose disorders, Current Diabetes Reviews, 2015; 11(1):51-57.

8. Harding JL, Backholer K, Williams ED, Peeters A, Cameron AJ, Hare MJL, Shaw JE, Magliano DJ. Psychosocial stress is positively associated with body mass index gain over 5 years: Evidence from the longitudinal AusDiab study. Obesity, 2014; 22(1):277-286.

9. Hare MJL, Magliano DJ, Zimmet PZ, Söderberg S, Joonas N, Pauvaday V, Larhubarbe J, Tuomilehto J, Kowelessur S, Alberti KGMM, Shaw JE. Glucose-independent ethnic differences in hemoglobin A1c in people without known diabetes. Diabetes Care, 2013; 36(6):1534-1540.

10. Hare MJL, Shaw JE and Zimmet PZ. Current controversies in the use of haemoglobin A1c. Journal of Internal Medicine, 2012; 271(3):227-236.